CLINICAL_TRIALS
trial_result
· 2019-09-04
Clinical Trial Update: Oxytocin as Adjunctive Treatment of Schizophrenia [Phase 2]
Summary
Phase 2 trial evaluating oxytocin as an adjunctive treatment for schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2019-09-04